Chronic myelogenous leukemia in patients withMPLorJAK2mutation-positive myeloproliferative neoplasm-Reference-Cited by-同舟云学术

Chronic myelogenous leukemia in patients withMPLorJAK2mutation-positive myeloproliferative neoplasm

Published:2015-06-18 Issue:6 Volume:37 Page:e150-e152
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int. Jnl. Lab. Hem.

Author:

Chen Z.¹²,Wang W.¹,Verstovsek S.³,Cortes J. E.³,Medeiros L. J.¹,Hu S.¹

Affiliation:

1. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Hematology; Hua-shan Hospital; Fudan University; Shanghai China

3. Departments of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Reference15 articles.

1. WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes;Alvarez-Larrán;Br J Haematol,2014

2. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay;Zhang;Int J Lab Hematol,2010

3. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation;Hussein;Leukemia,2008

4. The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report;Ursuleac;J Med Life,2013

5. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation;Pingali;Clin Lymphoma Myeloma,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination;Frontiers in Oncology;2024-01-12

2. Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis;International Journal of Hematology;2022-04-16

3. Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia;Leukemia Research;2021-01

4. Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor;Leukemia & Lymphoma;2020-07-22

5. Chronic Myeloid Leukemia;Practical Lymph Node and Bone Marrow Pathology;2020